Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| RMNI | Hershkowitz Steven | EVP & Chief Revenue Officer | 02.11.2026 | Verkauf | 4,98 | 42.482 | 211.390 | Form 4 |
| RDWR | Tauman Yair | Director | 30.10.2026 | Verkauf | 36,05 | 1.919 | 69.180 | Form 4 |
| RCL | Montiel Maritza Gomez | Director | 30.10.2026 | Verkauf | 307,21 | 400 | 122.884 | Form 4 |
| R | Gallo-Aquino Cristina | EVP and CFO | 29.10.2026 | Verkauf | 276,85 | 1.238 | 342.740 | Form 4 |
| RELL | Halverson Kenneth | Director | 29.10.2026 | Verkauf | 21,19 | 1.000 | 21.190 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 38,01 | 810 | 30.788 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 37,47 | 1.310 | 49.086 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 29.10.2026 | Verkauf | 36,14 | 480 | 17.347 | Form 4 |
| RBCAA | Starke Jeff | EVP, CHIEF INFORMATION OFFICER | 29.10.2026 | Verkauf | 92,91 | 3 | 279 | Form 4 |
| RBCAA | Starke Jeff | EVP, CHIEF INFORMATION OFFICER | 29.10.2026 | Verkauf | 92,40 | 817 | 75.491 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 28.10.2026 | Verkauf | 36,59 | 200.000 | 7.318.000 | Form 4 |
| RLAY | Rahmer Peter | See remarks | 28.10.2026 | Verkauf | 18,62 | 753 | 14.021 | Form 4 |
| RLAY | Bergstrom Donald A | President, R&D | 28.10.2026 | Verkauf | 18,62 | 2.252 | 41.932 | Form 4 |
| RLAY | Catinazzo Thomas | Chief Financial Officer | 28.10.2026 | Verkauf | 18,62 | 1.469 | 27.353 | Form 4 |
| RCL | Lake Robert Alexander | SVP, CLO & Secretary | 28.10.2026 | Verkauf | 298,43 | 1.000 | 298.430 | Form 4 |
| RELL | Ben Robert J | CFO, CAO, Corporate Secretary | 28.10.2026 | Verkauf | 21,01 | 5.000 | 105.050 | Form 4 |
| RDWR | Goldriech Rivkah | Chief People Officer | 28.10.2026 | Verkauf | 36,00 | 4.125 | 148.500 | Form 4 |
| RDWR | Aviv David Meleh | Chief Technology Officer | 28.10.2026 | Verkauf | 36,28 | 7.500 | 272.133 | Form 4 |
| R | Sanchez Robert E | Director | 28.10.2026 | Verkauf | 280,01 | 1.653 | 462.857 | Form 4 |
| RDWR | Goldriech Rivkah | Chief People Officer | 27.10.2026 | Verkauf | 35,01 | 100 | 3.501 | Form 4 |
| RDWR | Goldriech Rivkah | Chief People Officer | 27.10.2026 | Verkauf | 34,66 | 24.177 | 838.028 | Form 4 |
| RLYB | Lieber Jonathan I | Chief Financial Officer | 27.10.2026 | Verkauf | 16,04 | 599 | 9.608 | Form 4 |
| R | Sanchez Robert E | Director | 27.10.2026 | Verkauf | 282,22 | 1.539 | 434.337 | Form 4 |
| R | Sanchez Robert E | Director | 27.10.2026 | Verkauf | 281,50 | 6.535 | 1.839.603 | Form 4 |
| R | Sanchez Robert E | Director | 27.10.2026 | Verkauf | 280,44 | 13.326 | 3.737.143 | Form 4 |
| R | Sanchez Robert E | Director | 27.10.2026 | Verkauf | 283,00 | 4.950 | 1.400.850 | Form 4 |
| RS | Koch Stephen Paul | Exec. VP, COO | 27.10.2026 | Verkauf | 432,23 | 1.004 | 433.959 | Form 4 |
| RS | Koch Stephen Paul | Exec. VP, COO | 27.10.2026 | Verkauf | 431,22 | 3.136 | 1.352.306 | Form 4 |
| RS | Koch Stephen Paul | Exec. VP, COO | 27.10.2026 | Verkauf | 430,28 | 4.194 | 1.804.594 | Form 4 |
| RDWR | Aviv David Meleh | Chief Technology Officer | 27.10.2026 | Verkauf | 35,13 | 10.000 | 351.250 | Form 4 |
| RDWR | Aviv David Meleh | Chief Technology Officer | 27.10.2026 | Verkauf | 34,12 | 7.500 | 255.875 | Form 4 |
| RGR | Wilson Michael W | VP of New Product Development | 26.10.2026 | Verkauf | 45,47 | 628 | 28.555 | Form 4 |
| RVMD | Mancini Anthony | See Remarks | 26.10.2026 | Verkauf | 186,99 | 2.310 | 431.947 | Form 4 |
| R | Sanchez Robert E | Director | 26.10.2026 | Verkauf | 283,57 | 6.611 | 1.874.681 | Form 4 |
| ROP | Stipancich John K | EVP, Chief Legal Officer & Sec | 26.10.2026 | Verkauf | 449,04 | 3.500 | 1.571.640 | Form 4 |
| RDWR | Aviv David Meleh | Chief Technology Officer | 26.10.2026 | Verkauf | 32,05 | 12.500 | 400.625 | Form 4 |
| ROP | Conley Jason | EVP, Chief Financial Officer | 23.10.2026 | Verkauf | 436,01 | 1.469 | 640.499 | Form 4 |
| ROP | Conley Jason | EVP, Chief Financial Officer | 23.10.2026 | Verkauf | 435,53 | 10.105 | 4.401.031 | Form 4 |
| ROP | Conley Jason | EVP, Chief Financial Officer | 23.10.2026 | Verkauf | 433,86 | 426 | 184.824 | Form 4 |
| RMD | Rider Michael J | Global General Counsel | 23.10.2026 | Verkauf | 255,00 | 400 | 102.000 | Form 4 |
| RAPP | Ceesay Abraham | Chief Executive Officer | 21.10.2026 | Verkauf | 29,16 | 2.210 | 64.448 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 20.10.2026 | Verkauf | 35,42 | 14.144 | 500.980 | Form 4 |
| ROIV | Venker Eric | President & Immunovant CEO | 20.10.2026 | Verkauf | 35,09 | 185.856 | 6.521.687 | Form 4 |
| RM | Atwood Catherine R | SVP and General Counsel | 19.10.2026 | Verkauf | 35,01 | 200 | 7.002 | Form 4 |
| RARE | Horn Howard | Chief Financial Officer | 15.10.2026 | Verkauf | 15,27 | 7.066 | 107.898 | Form 4 |
| RCAT | Thompson Jeffrey M | Chairman of the Board, CEO | 15.10.2026 | Verkauf | 4,51 | 150.000 | 676.500 | Form 4 |
| ROKU | Jedda Dan | CFO & COO | 15.10.2026 | Verkauf | 152,84 | 7.000 | 1.069.880 | Form 4 |
| RPAY | Dempsey Tyler B | General Counsel | 15.10.2026 | Verkauf | 4,05 | 610 | 2.471 | Form 4 |
| RSKD | Kumaraswami Ravi | Pres. Worldwide Field Ops. | 15.10.2026 | Verkauf | 8,36 | 65.000 | 543.127 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 155,91 | 1.361 | 212.194 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 154,88 | 1.639 | 253.848 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 154,03 | 2.100 | 323.463 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 152,82 | 5.701 | 871.227 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 152,14 | 5.495 | 836.009 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 150,87 | 11.200 | 1.689.744 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 150,08 | 6.399 | 960.362 | Form 4 |
| RDDT | Wong Jennifer L. | Chief Operating Officer | 14.10.2026 | Verkauf | 148,86 | 26.105 | 3.885.990 | Form 4 |
| RAL | Newcombe Tamara S. | President and CEO | 14.10.2026 | Verkauf | 70,58 | 12.936 | 913.023 | Form 4 |
| RPAY | Dempsey Tyler B | General Counsel | 14.10.2026 | Verkauf | 4,00 | 4.886 | 19.544 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 781,47 | 50 | 39.074 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).